METHOD FOR ASSESSING AND PREDICTING EFFICACY OF BREAST CANCER TREATMENT WITH A LONG-ACTING TOPOISOMERASE I INHIBITOR

摘要

Provided is a method of treating an individual suffering from a cancer such as breast cancer by administering to the individual a long- acting topoisomerase I inhibitor such as SN-38 or irinotecan, and correlating the level of at least one tumor marker such as CA27.29 in the individual with response of the cancer to treatment with the long- acting topoisomerase I inhibitor, to thereby provide a method for predicting and assessing the therapeutic efficacy of the treatment.